for sensitive chromatographic and analytical workflows requiring minimal baseline interference.
Store at -20°C,Argon charged Ships Ice chest + Ice pads Check lot-specific COA for exact specifications.
SDS, COA, datasheet, and spec sheet available for download. Lot-specific COA accessible via lot number lookup.
Cited in 4 peer-reviewed publications across chromatography, organic synthesis, and cross-coupling reactions.
DSPE-PEG-2K-CH2COOH is a PEG derivative containing DSPE and biotin end groups. The DSPE-PEGs have been FDA approved for medical applications. The hydrophobic properties of the DSPE allow for the encapsulation and congregation of other hydrophobic drugs. The hydrophilic PEG linker increases the water solubility of the overall compound allowing for the delivery of the drug. The CH2COOH group can be reacted with primary amines in the presence of activators such as EDC and DCC to form stable amide bonds.
| Pubchem Sid | 528764238 |
|---|---|
| Sourires canoniques | CCCCCCCCCCCCCCCCCC(=O)OCC(COP(=O)(O)OCCNC(=O)OCCOCC(=O)O)OC(=O)CCCCCCCCCCCCCCCCC.N |
| IUPAC Name | azane;2-[2-[2-[2,3-di(octadecanoyloxy)propoxy-hydroxyphosphoryl]oxyethylcarbamoyloxy]ethoxy]acetic acid |
| InChIKey | MFOLYTNLQCGGBD-UHFFFAOYSA-N |
| INCHI | 1S/C46H88NO13P.H3N/c1-3-5-7-9-11-13-15-17-19-21-23-25-27-29-31-33-44(50)57-39-42(40-59-61(53,54)58-36-35-47-46(52)56-38-37-55-41-43(48)49)60-45(51)34-32-30-28-26-24-22-20-18-16-14-12-10-8-6-4-2;/h42H,3-41H2,1-2H3,(H,47,52)(H,48,49)(H,53,54);1H3 |
Comprehensive hazard, handling, storage, and regulatory compliance document.
Download SDS →Lot-specific quality data. Enter your lot number to retrieve the exact COA.
Look up COA →Full quality attributes and acceptance criteria for this grade.
View spec sheet →Find and download the COA for your product by matching the lot number on the packaging.
| Lot Number | Certificate Type | Date | Article |
|---|---|---|---|
 E2530348 | Certificate of Analysis | May 24, 2025 | D596707 |
| E2530355 | Certificate of Analysis | May 24, 2025 | D596707 |
| E2530356 | Certificate of Analysis | May 24, 2025 | D596707 |
| E2530357 | Certificate of Analysis | May 24, 2025 | D596707 |
| E2530358 | Certificate of Analysis | May 24, 2025 | D596707 |
| 1. Xiaojuan Hu, Xingwen Cheng, Liqiang Shao, Lan Yang, Gongning Chen, Zhangwei Yan, Mengdie Yu, Yehui Kang, Xiaozhou Mou, Xianghong Yang, Yu Cai. (2025) NIR-II Light-Controlled Photosynthetic Activation via an Upconversion Nanoplatform for Targeted Bioenergetic Therapy in Acute Kidney Injury. JOURNAL OF MEDICINAL CHEMISTRY, [PMID:40934095] [10.1021/acs.jmedchem.5c02109] |
| 2. Yehui Kang, Yahui Zhang, Weijiao Fan, Liya Yu, Mengdie Yu, Yuejia Ding, Yu Cai, Aihong Jiao, Jiajie Xu. (2026) NIR-II conjugated polymer/emodin nanoplatform for mild photothermal therapy/pyroptosis of head and neck squamous cell carcinoma. JOURNAL OF COLLOID AND INTERFACE SCIENCE, [PMID:41483565] [10.1016/j.jcis.2025.139800] |
| 3. Jian-Xuan Sun, Ye An, Si-Han Zhang, Jin-Zhou Xu, Abudureyimu Maimaiti, Jing-Yu Xu, Yi-Fan Huang, Yu-Xuan yang, Mei-Cheng Liu, Shao-Gang wang, Qi-Dong Xia. (2026) Magnetically navigated and PSMA/STEAP1 dual-targeted nanoliposomes for NIR-II/MRI imaging with photothermal-chemo-immunotherapy for prostate cancer. Research, [PMID:42602257] [10.34133/research.1375] |
| 4. Jiarong Liang, Si Wang, Zhonghui Ma, Fei Kuang, Xiangkun Li, Zhilong Gong, Jinzhu Su, Zhiyi Wang. (2026) Zwitterionic Polarization-Engineering Covalent Organic Frameworks for Targeted Ferroptosis-Synergistic Photothermal Immunotherapy. Advanced Healthcare Materials, [PMID:42675659] [10.1002/adhm.71663] |
| 5. Jiayi Zhang, Chi Ma, Haifeng Zhang, Haibing Wang, Siya Wang, Xueting Ren, Licheng Zhang, Menghuan Li, Zhong Luo, Xiang Cui. (2026) Injectable ECM-mimetic hydrogels enable coordinated mitochondrial rejuvenation of senescent nucleus pulposus cells for repairing degenerative intervertebral discs. CHEMICAL ENGINEERING JOURNAL, [PMID:] [10.1016/j.cej.2026.180365] |
